Cargando…
Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids: A Bayesian Reanalysis of a Previous Meta-analysis
IMPORTANCE: A World Health Organization (WHO) meta-analysis found that tocilizumab was associated with reduced mortality in hospitalized patients with COVID-19. However, uncertainty remains concerning the magnitude of tocilizumab’s benefits and whether its association with mortality benefit is simil...
Autores principales: | Albuquerque, Arthur M., Tramujas, Lucas, Sewanan, Lorenzo R., Williams, Donald R., Brophy, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886529/ https://www.ncbi.nlm.nih.gov/pubmed/35226077 http://dx.doi.org/10.1001/jamanetworkopen.2022.0548 |
Ejemplares similares
-
Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis
por: Albuquerque, Arthur M., et al.
Publicado: (2023) -
Insights from the reanalysis of high-throughput chemical genomics data for Escherichia coli K-12
por: Wu, Peter I-Fan, et al.
Publicado: (2020) -
Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis
por: Lee, Todd C., et al.
Publicado: (2021) -
Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings
por: Hoek, Joyce M., et al.
Publicado: (2021) -
Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)